
Medtronic PLC
MDT - NEW YORK STOCK EXCHANGE, INC.
Industry: Health Care
Market Cap: 122.0 B
IPO Date: Nov 21, 1977
Country: IE
Currency: USD
Shares Outstanding: 1.3 B
6 month performance
Recent News
Dividend Champion, Contender, And Challenger Highlights: Week Of September 21
9/19/2025
This is our weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest in the article series here.

Source: SeekingAlpha
Why Medtronic (MDT) Should Be Part of Your Dividend Stock Portfolio in 2025
9/19/2025
Medtronic plc (NYSE:MDT) is included among the Best Stocks for a Dividend Stock Portfolio. Medtronic plc (NYSE:MDT), one of the leading names in medical devices, has faced some challenges in recent years but has taken measures to address them, with a particular emphasis on strengthening profitability. In the past, the company considered spinning off certain divisions […]

Source: Yahoo
Smart Medical Devices Market Size to Reach $180.4 Billion by 2033 - Strategic Growth Opportunities in Chronic Disease Management, Digital Health, and Connected Care
9/19/2025
The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at a CAGR of 12.8% (2025–2033), according to the latest report from DataM Intelligence.

Source: Yahoo
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
9/19/2025
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ device. The minimally invasive implantable tibial neuromodulation (ITNM) therapy is inserted near the ankle and designed to treat urge urinary incontinence.

Source: Yahoo
Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue?
9/18/2025
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Source: Yahoo
J&J launches IVL device in Europe; Medtronic looks at pacing for more patients
9/18/2025
J&J’s Shockwave Javelin intravascular lithotripsy catheter treats people with peripheral artery disease. Elsewhere, Medtronic began a pivotal trial to evaluate its pacemakers in a new patient group.

Source: Yahoo
AI in Remote Patient Monitoring Market Projected to Reach US$ 10.35 Billion by 2033, Expanding at 6.7% CAGR, According to DataM Intelligence
9/18/2025
According to DataM Intelligence, the global AI in remote patient monitoring market reached US$ 5.45 billion in 2023, with a rise to US$ 5.78 billion in 2024, and is expected to reach US$ 10.35 billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025–2033.

Source: Yahoo
1 Reason Every Investor Should Know About Medtronic (MDT)
9/17/2025
The storied medical device specialist always seems to post encouraging growth.

Source: Yahoo
Medtronic: Buy This Dividend Aristocrat While It's Good Value
9/17/2025
MDT delivered solid fiscal Q1 2026 results, with 8.4% revenue growth and standout performance in Cardiac Ablation and Diabetes segments. Read the latest analysis on the stock here.

Source: SeekingAlpha
Europe Stereotactic Neuro-Navigation System Research Report 2025 | Market to Surpass $1 Billion by 2035 with Medtronic, Brainlab, and Elekta at the Forefront
9/16/2025
The Europe stereotactic neuro-navigation system market is poised to expand from $269.0 million in 2024 to $1.01 billion by 2035, with a CAGR of 13.14%. This growth is driven by increased prevalence of neurological illnesses, advantages of navigation-assisted surgeries, and technological advancements like AI and augmented reality. The demand for minimally invasive procedures and precise surgical guidance further fuels the market. However, high costs and integration challenges pose barriers. Despi

Source: Yahoo
Europe Robotic Neurosurgery Analysis Report 2025 | Market to Reach $585 Million by 2035 with Brainlab, Renishaw, and Medtronic Leading
9/16/2025
The Europe robotic neurosurgery market is poised for substantial growth, projected to hit $585.3 million by 2035 from an estimated $93.1 million in 2024, with a CAGR of 17.83% from 2025 to 2035. The rising prevalence of neurological disorders is driving demand for advanced surgical techniques, bolstered by AI-enabled guidance and precision robotics. Europe's established healthcare system, favorable reimbursement policies, and a shift towards minimally invasive surgeries are key growth factors. C

Source: Yahoo
1 Reason Intuitive Surgical (ISRG) Is 1 of the Best Healthcare Stocks You Can Buy Today
9/16/2025
Find out how the company's da Vinci surgical robots could remain the preferred option for decades.

Source: Yahoo
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
9/15/2025
Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045 (collectively, the "Notes"). All of Medtronic, Inc.'s obligations under the Notes will be fully and unconditionally guaranteed by the Company and Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), a wholly-ow

Source: Yahoo
Medtronic (MDT) Launches Global Study On Novel Heart Failure Treatment
9/15/2025
Medtronic (MDT) has recently initiated the ELEVATE-HFpEF study focusing on heart failure treatment, which, alongside other product developments and strategic initiatives, coincides with a positive quarter-end price movement of 9%. This period saw advancements such as the launch of the Hugo™ robotic-assisted surgery system and FDA approval for the MiniMed™ 780G system, which likely supported investor sentiment. The broader market trend was upward, with indexes reaching record highs amid...

Source: Yahoo
ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?
9/15/2025
Intuitive Surgical shares are down 13% in three months as margin pressures weigh on the stock, but strong procedure growth keeps its long-term story intact.

Source: Yahoo
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
9/15/2025
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the initiation of a pivotal study evaluating the use of elevated and personalized cardiac pacing rates for the treatment of patients with Heart Failure with preserved Ejection Fraction (ELEVATE-HFpEF, NCT06678841). Physicians routinely use pacing therapy to treat patients whose hearts beat too slowly (bradycardia). This study, however, will investigate a potential novel treatment for patients with HFpEF by using

Source: Yahoo
Is Medtronic’s 17% Rally Justified After Strong Earnings and Bullish Guidance?
9/15/2025
Thinking about what to do with Medtronic stock? You’re not alone. If you’re looking to make a move, or just want to know whether to hang tight, recent market signals have brought Medtronic back to the head of a lot of investor watchlists. With a steady closing price of $94.03, the stock has edged up by 1.1% over both the past week and the last 30 days. The bigger story, however, is a 17.2% rise year-to-date and a 7.8% bump over the past year. This suggests renewed confidence and a degree of...

Source: Yahoo
Opportunities in the Home Infusion Therapy Market 2025-2035 Featuring Strategic Analysis of Baxter International, B. Braun Melsungen, Fresenius Kabi, Medtronic, Terumo and More
9/15/2025
The market offers opportunities through increasing adoption due to rising chronic diseases, telehealth integration, and technological advancements. However, reimbursement challenges persist. North America leads due to favorable policies and demographics. Competitive growth is driven by innovation and market expansion.Dublin, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The "Home Infusion Therapy Market by Product Type, Application, Service Model - Global Market Size, Segmental Analysis, Regional Overview,

Source: Yahoo
Billionaire Ken Griffin Piled Into These 2 Unstoppable Dividend Stocks During the Second Quarter
9/13/2025
They have increased their payouts for a combined 111 straight years.

Source: Yahoo
Medtronic PLC stock outperforms competitors on strong trading day
9/11/2025
Medtronic PLC stock outperforms competitors on strong trading day
Source: MarketWatch